CEPHEID is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets.
The company’s systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Cepheid’s easy-to-use systems integrate a number of complicated and timeintensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease in the clinical market. A range of Xpert assays are now launched for processing on the GeneXpert PCR platform including MRSA, C. difficile, vancomycin resistant enterococci, Group B streptococcus and enteroviruses. Rapid turn around, coupled with on demand testing capabilities enables efficient management of patients.
